FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yeul Hong Kim

Research Profile

Disorders

Procedures

Concepts & Ideas

Geographic Areas

Korea

Anatomy

Tumor Cell Line

Chemicals & Drugs

Living Beings

Asian Continental Ancestry Group

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Co-author Network

Publications

TOP 3
Myung Han Hyun; Mi Ran Shin; Yeul Hong Kim
Regorafenib for metastatic colorectal cancer.
Joo Hee Park; Young Je Park; Jae Hong Seo; Deuk Jae Sung; Jun Cheon; In Keun Choi; Sung Gu Kang; Seok Ho Kang; Hye Sook Kim; Jun Suk Kim; Seung Tae Kim; Yeul Hong Kim; Young Hwii Ko; Soon Wook Lee; Sang Cheul Oh; Kyong Hwa Park
Combination of gemcitabine and carboplatin as first line treatment in elderly patients or those unfit for cisplatin-based chemotherapy with advanced transitional cell carcinoma of the urinary tract.
Seung Tae Kim; Kyong Hwa Park; Sang Won Shin; Jun Suk Kim; Yeul Hong Kim
Impact of KRAS Mutation Status on Outcomes in Metastatic Colon Cancer Patients without Anti-Epidermal Growth Factor Receptor Therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yeul Hong Kim (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Myung Han Hyun; Mi Ran Shin; Yeul Hong Kim
Regorafenib for metastatic colorectal cancer.
Lancet 2013;381(9877):1537-8.
2013: Joo Hee Park; Young Je Park; Jae Hong Seo; Deuk Jae Sung; Jun Cheon; In Keun Choi; Sung Gu Kang; Seok Ho Kang; Hye Sook Kim; Jun Suk Kim; Seung Tae Kim; Yeul Hong Kim; Young Hwii Ko; Soon Wook Lee; Sang Cheul Oh; Kyong Hwa Park
Combination of gemcitabine and carboplatin as first line treatment in elderly patients or those unfit for cisplatin-based chemotherapy with advanced transitional cell carcinoma of the urinary tract.
Cancer chemotherapy and pharmacology 2013;71(4):1033-9.
2013: Seung Tae Kim; Kyong Hwa Park; Sang Won Shin; Jun Suk Kim; Yeul Hong Kim
Impact of KRAS Mutation Status on Outcomes in Metastatic Colon Cancer Patients without Anti-Epidermal Growth Factor Receptor Therapy.
Cancer research and treatment : official journal of Korean Cancer Association 2013;45(1):55-62.
2013: Seung Tae Kim; Kyong Hwa Park; Sang Won Shin; Jae Sook Sung; Uk Hyun Jo; Yeul Hong Kim
Can mutations of EGFR and KRAS in serum be predictive and prognostic markers in patients with advanced non-small cell lung cancer (NSCLC)?
Medical oncology (Northwood, London, England) 2013;30(1):328.
2013: Seung Tae Kim; Koichi Hagiwara; Uk Hyun Jo; Hae-Yun Jung; Jun Suk Kim; Kyong Hwa Park; Sang Won Shin; Jae Sook Sung; Tomoaki Tanaka; Yeul Hong Kim
Can serum be used for analyzing the EGFR mutation status in patients with advanced non-small cell lung cancer?
American journal of clinical oncology 2013;36(1):57-63.
2013: Young Mi Whang; Ukhyun Jo; Hyun Jung Ju; Hyun Kyung Kim; In Song Koh; Jong Won Lee; Kyong Hwa Park; Jae Sook Sung; Yeul Hong Kim
Wnt5a is associated with cigarette smoke-related lung carcinogenesis via protein kinase C.
PloS one 2013;8(1):e53012.
2012: Jong-Mu Sun; Hwan Jung Yun; Jin Seok Ahn; Myung-Ju Ahn; In Gyu Hwang; Sook Jung Jo; Bong-Seog Kim; Hoon-Kyo Kim; Sang-We Kim; Yeul Hong Kim; Dae Ho Lee; Jae Won Lee; Keehyun Lee; Ki Hyeong Lee; Young Joo Min; Keunchil Park; Hong Suk Song
Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01): an open-label, phase 3 trial.
Cancer 2012;118(24):6234-42.
2012: Hae-Yun Jung; Hyun-Jung Joo; Jong Kuk Park; Yeul Hong Kim
The Blocking of c-Met Signaling Induces Apoptosis through the Increase of p53 Protein in Lung Cancer.
Cancer research and treatment : official journal of Korean Cancer Association 2012;44(4):251-61.
2012: Seung Hyun Oh; Ki-Hoon Song; Young Mi Whang; Hye-Young Min; Bonnie S Glisson; Seung Ho Han; Ju-Hee Kang; Yeul Hong Kim; Ho-Young Lee
Histone deacetylase inhibitors enhance the apoptotic activity of insulin-like growth factor binding protein-3 by blocking PKC-induced IGFBP-3 degradation.
International journal of cancer. Journal international du cancer 2012;131(10):2253-63.
2012: Jae Sook Sung; Kyong Hwa Park; Lihua Jin; Ukhyun Jo; Yeul Hong Kim
Association between -276 C/T polymorphism of the ERBB3 gene and lung cancer risk in a Korean population.
Anticancer research 2012;32(10):4433-7.
2012: Yeul Hong Kim; Ioannis Lainas; Jen-Shi Chen; Su-Pin Choo; Kent-Man Chu; Christine DelaCruz; Pralay Mukhopadhyay; Kei Muro; Se-Hoon Park; Min-Hee Ryu; Teresa Sanchez; Hirofumi Yasui; Chung-Pin Li
A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy.
Cancer chemotherapy and pharmacology 2012;70(4):583-90.
2012: Jae Sook Sung; Kyong Hwa Park; Seung Tae Kim; Yeul Hong Kim
Discovery and Evaluation of Polymorphisms in the AKT2 and AKT3 Promoter Regions for Risk of Korean Lung Cancer.
Genomics & informatics 2012;10(3):167-74.
2012: Sung-Joon Park; Kyu-Sang Song; Oh-Hyung Kwon; Seung-Moo Noh; Jong-Lyul Park; Hay-Ran Jang; Jeong-Hwan Kim; Mirang Kim; Seon-Young Kim; Yeul Hong Kim; Yong Sung Kim
Epigenetic alteration of CCDC67 and its tumor suppressor function in gastric cancer.
Carcinogenesis 2012;33(8):1494-501.
2012: Eun Young Gil; Hoiseon Jeong; Uk Hyun Jo; Aeree Kim; Yeul Hong Kim; Insong Koh; Eun Sook Lee; Jae Hong Seo; Young Mi Whang; Ok Hee Woo; Kyu Ran Cho; Kyong Hwa Park
Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer.
International journal of oncology 2012;41(2):611-20.
2012: Seung Tae Kim; Jun Suk Kim; Sang Cheul Oh; Kyong Hwa Park; Jae Hong Seo; Sang Won Shin; Yeul Hong Kim
Is chemotherapy in elderly patients with metastatic or recurrent gastric cancer as tolerable and effective as in younger patients?
Asia-Pacific journal of clinical oncology 2012;8(2):194-200.
2012: Yoon Ji Choi; Jun Suk Kim; Seung Tae Kim; Sang Cheul Oh; Kyong Hwa Park; Jae Hong Seo; Sang Won Shin; Yeul Hong Kim
The serum bone morphogenetic protein-2 level in non-small-cell lung cancer patients.
Medical oncology (Northwood, London, England) 2012;29(2):582-8.
2012: Seung Tae Kim; Yeul Hong Kim; Sang Cheul Oh; Kyong Hwa Park; Jae Hong Seo; Jun Suk Kim; Sang Won Shin
Chemotherapy in Patients Older than or Equal to 75 Years with Advanced Non-small Cell Lung Cancer.
Cancer research and treatment : official journal of Korean Cancer Association 2012;44(1):37-42.
2012: Myung-Ju Ahn; Hojoong Kim; Jhingook Kim; Jong-Won Kim; Kwhanmien Kim; Yeul Hong Kim; O Jung Kwon; Jeeyun Lee; Seung-Tae Lee; Jae Yong Park; Yeon Hee Park; Young Mog Shim; Jong-Mu Sun; Hong-Hee Won; Jin Seok Ahn; Keunchil Park
The 18p11.22 locus is associated with never smoker non-small cell lung cancer susceptibility in Korean populations.
Human genetics 2012;131(3):365-72.
2012: Seung Tae Kim; Yoon Ji Choi; Jun Suk Kim; Sang Cheul Oh; Kyong Hwa Park; Jae Hong Seo; Sang Won Shin; Yeul Hong Kim
A prognostic model to identify patients with advanced pancreas adenocarcinoma who could benefit from second-line chemotherapy.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2012;24(2):105-11.
2012: Yung-Jue Bang; Peter Button; Jae Yong Cho; Hyun Cheol Chung; Jiafu Ji; Yeul Hong Kim; Yong Ho Kim; Young-Woo Kim; Kyung Hee Lee; Keun-Wook Lee; Young Jae Mok; Sung Hoon Noh; Sang-Ik Noh; Young-Kyu Park; Florin Sirzén; Han-Kwang Yang; Ta-Sen Yeh
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.
Lancet 2012;379(9813):315-21.
2012: Seung Tae Kim; Jun Suk Kim; Sang Cheul Oh; Kyong Hwa Park; Jae Hong Seo; Sang Won Shin; Yeul Hong Kim
How does inhibition of the renin-angiotensin system affect the prognosis of advanced gastric cancer patients receiving platinum-based chemotherapy?.
Oncology 2012;83(6):354-60.
2012: Seung Tae Kim; Jun Suk Kim; Sang Cheul Oh; Kyong Hwa Park; Jae Hong Seo; Sang Won Shin; Yeul Hong Kim
Varicella zoster virus infection during chemotherapy in solid cancer patients.
Oncology 2012;82(2):126-30.
2012: Oh-Hyung Kwon; Seung-Moo Noh; Sang-Gi Paik; Sung-Joon Park; David Pocalyko; Kyu-Sang Song; Yuli Wang; Hyang-Sook Yoo; Tae-Wook Kang; Jeong-Hwan Kim; Mirang Kim; Seon-Young Kim; Yeul Hong Kim; Yong Sung Kim
Elevated fibroblast growth factor-inducible 14 expression promotes gastric cancer growth via nuclear factor-κB and is associated with poor patient outcome.
Cancer letters 2012;314(1):73-81.
2011: Sang Joon Shin; Dae Young Zang; Jae Heon Jeong; Tae Won Kim; Yeul Hong Kim; Yong Tai Kim; Kyung Hee Lee; Myung Ah Lee; Do Youn Oh; Young Suk Park; Jae Kyung Roh; Byoung Yong Shim; Joong Bae Ahn
Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer.
Investigational new drugs 2011;29(5):1073-80.
2011: Wonbeak Yoo; Hae-Yun Jung; Jun Suk Kim; Seungjoon Lim; Kyong Hwa Park; Jeong Seon Ryu; Jae Hong Seo; Sang Won Shin; Jae Sook Sung; Yeul Hong Kim
An association study of polymorphisms in JAK3 gene with lung cancer in the Korean population.
Cancer research and treatment : official journal of Korean Cancer Association 2011;43(2):108-16.
2011: Hee Yeon Seo; Hyun Joo Lee; Ok Hee Woo; Kyong Hwa Park; Sang Uk Woo; Dae Sik Yang; Ae-Ree Kim; Jae-Bok Lee; Eun Sook Lee; Yeul Hong Kim; Jun Suk Kim; Jae Hong Seo
Phase II study of vinorelbine monotherapy in anthracycline and taxane pre-treated metastatic breast cancer.
Investigational new drugs 2011;29(2):360-5.
2011: Dae Sik Yang; Kyong Hwa Park; Ok Hee Woo; Sang Uk Woo; Ae-Ree Kim; Eun Sook Lee; Jae-Bok Lee; Yeul Hong Kim; Jun Suk Kim; Jae Hong Seo
Association of a vascular endothelial growth factor gene 936 C/T polymorphism with breast cancer risk: a meta-analysis.
Breast cancer research and treatment 2011;125(3):849-53.
2011: Jae Weon Kim; Cheol Keun Park; Seong Hoe Park; Yeul Hong Kim; June Hyun Han; Chae-Yong Kim; C-H Sohn; Kee-Hyun Chang; Hee-Won Jung
Relationship between radiological characteristics and combined 1p and 19q deletion in World Health Organization grade III oligodendroglial tumours.
Journal of neurology, neurosurgery, and psychiatry 2011;82(2):224-7.
2011: Jae-Bok Lee; Ok Hee Woo; Kyong Hwa Park; Sang Uk Woo; Dae Sik Yang; Ae-Ree Kim; Eun Sook Lee; Yeul Hong Kim; Jun Suk Kim; Jae Hong Seo
Bevacizumab for salvage treatment of metastatic breast cancer: a systemic review and meta-analysis of randomized controlled trials.
Investigational new drugs 2011;29(1):182-8.
2011: Min-Kyoung Kim; Yeul Hong Kim; Jong-Kyu Woo; Dae-Han Choi; Yun Choi; Yoon Kyung Jeon; Chul-Woo Kim
The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1.
Molecular cancer 2011;10():98.
2011: Seung Tae Kim; Yoon Ji Choi; Kyong Hwa Park; Sang Cheul Oh; Jae Hong Seo; Sang Won Shin; Jun Suk Kim; Yeul Hong Kim
Epidermal growth factor receptor mutations as a prognostic factor in Korean patients with advanced lung adenocarcinoma who had not been treated with received epidermal growth factor receptor tyrosine kinase inhibitors.
Chemotherapy 2011;57(2):108-14.
2010: Eun Joo Kang; Yoon Ji Choi; Jung Seon Kim; Seung Tae Kim; Kyong Hwa Park; In Keun Choi; Sang Chul Oh; Jae Hong Seo; Sang Won Shin; Jun Suk Kim; Yeul Hong Kim
Mitomycin-C, 5-fluorouracil, and leucovorin as a salvage therapy in patients with metastatic colorectal adenocarcinoma.
Asia-Pacific journal of clinical oncology 2010;6(4):286-91.
2010: Hee Yeon Seo; Joong-Min Park; Kyong Hwa Park; Seok Jin Kim; Sang Cheul Oh; Byung Soo Kim; Yeul Hong Kim; Jun Suk Kim
Prognostic significance of serum vascular endothelial growth factor per platelet count in unresectable advanced gastric cancer patients.
Japanese journal of clinical oncology 2010;40(12):1147-53.
2010: Ho Il Yoon; Yun-Chul Hong; Sang-Heon Cho; Hojoong Kim; Yeul Hong Kim; J R Sohn; M Kwon; Seong Hoe Park; Myung-Haing Cho; Hae-Kwan Cheong
Exposure to volatile organic compounds and loss of pulmonary function in the elderly.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2010;36(6):1270-6.
2010: Yong Park; Myoung Hee Kang; Hee Yeon Seo; Joong-Min Park; Chul Won Choi; Yeul Hong Kim; In Sun Kim; Jun Suk Kim; Sang Cheul Oh
Bone morphogenetic protein-2 levels are elevated in the patients with gastric cancer and correlate with disease progression.
Medical oncology (Northwood, London, England) 2010;27(4):1192-9.
2010: Uk Hyun Jo; Young Mi Whang; Jae Sook Sung; Yeul Hong Kim
Methylation of AKAP12{alpha} promoter in lung cancer.
Anticancer research 2010;30(11):4595-600.
2010: Sang Uk Woo; Kyong Hwa Park; Ok Hee Woo; Dae Sik Yang; Ae-Ree Kim; Eun Sook Lee; Jae-Bok Lee; Yeul Hong Kim; Jun Suk Kim; Jae Hong Seo
Association of a TGF-β1 gene -509 C/T polymorphism with breast cancer risk: a meta-analysis.
Breast cancer research and treatment 2010;124(2):481-5.
2010: Chul-Kyu Park; J H Bae; H Y Kim; H J Jo; Yeul Hong Kim; Sung Jun Jung; Jong S Kim; Seog Bae Oh
Substance P sensitizes P2X3 in nociceptive trigeminal neurons.
Journal of dental research 2010;89(10):1154-9.
2010: Hyun Kyung Kim; Hae-Yun Jung; Seungjoon Lim; JAE SOOK SUNG; Young Mi Whang; Ukhyun Jo; Jong Eun Lee; Sang Won Shin; Jun Suk Kim; Jeong Seon Ryu; Yeul Hong Kim
A study of RET proto-oncogene polymorphisms in association with lung cancer risk in the Korean population.
Anticancer research 2010;30(9):3621-7.
2010: Kyong Hwa Park; Jeong Sun Kim; Yong Park; Hee Yun Seo; Young Je Park; In Keun Choi; Sang Cheul Oh; Jae Hong Seo; Chul Yong Kim; Kwang Yoon Jung; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim; Nam Joon Lee
Concurrent chemoradiation followed by adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma in Korea.
Cancer chemotherapy and pharmacology 2010;66(4):643-51.
2010: In Keun Choi; Yeul Hong Kim; Jun Suk Kim; Jae Hong Seo
High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer.
Acta oncologica (Stockholm, Sweden) 2010;49(6):861-4.
2010: Jee Hyun Kim; Keun-Wook Lee; Yeul Hong Kim; Kyung Hee Lee; Do Youn Oh; Joonhee Kim; Sung Hyun Yang; Seock-Ah Im; Sung Ho Choi; Yung-Jue Bang
Individualized tumor response testing for prediction of response to Paclitaxel and Cisplatin chemotherapy in patients with advanced gastric cancer.
Journal of Korean medical science 2010;25(5):684-90.
2010: JAE SOOK SUNG; Kyong Hwa Park; Yeul Hong Kim
Genomic alterations of chromosome region 11p as predictive marker by array comparative genomic hybridization in lung adenocarcinoma patients.
Cancer genetics and cytogenetics 2010;198(1):27-34.
2010: Yong Park; Dae Sik Kim; Seh Jong Park; Hee Yun Seo; Se Ryeon Lee; Hwa Jung Sung; Kyong Hwa Park; In Keun Choi; Seok Jin Kim; Sang Cheul Oh; Jae Hong Seo; Chul Won Choi; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
The suggestion of a risk stratification system for febrile neutropenia in patients with hematologic disease.
Leukemia research 2010;34(3):294-300.
2010: Joung-Soon Jang; Ho Yeong Lim; In Gyu Hwang; Hong Suk Song; NaeChoon Yoo; SoYoung Yoon; Yeul Hong Kim; Eunsik Park; Jae Ho Byun; Myung Ah Lee; Suk Joong Oh; Kyung Hee Lee; Bong-Seog Kim; Sang Cheul Oh; Sam Yong Kim; Sang Jae Lee
Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial.
Cancer chemotherapy and pharmacology 2010;65(4):641-7.
2010: Do-Youn Oh; Yongjun Cha; In-Sil Choi; So-Young Yoon; In Keun Choi; Jee Hyun Kim; Sang Cheul Oh; Chang Duck Kim; Jae Sun Kim; Yung-Jue Bang; Yeul Hong Kim
A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer.
Cancer chemotherapy and pharmacology 2010;65(3):527-36.
2010: Dae Sik Yang; Hwa Jung Sung; Ok Hee Woo; Kyong Hwa Park; Sang Uk Woo; Ae-Ree Kim; Eun Sook Lee; Jae-Bok Lee; Yeul Hong Kim; Jun Suk Kim; Jae Hong Seo
Association of a progesterone receptor gene +331 G/A polymorphism with breast cancer risk: a meta-analysis.
Cancer genetics and cytogenetics 2010;196(2):194-7.
2010: Seung Tae Kim; Kyong Hwa Park; Sang Cheul Oh; Jae Hong Seo; Sang Won Shin; Jun Suk Kim; Yeul Hong Kim
Selection of a patient subgroup with advanced esophageal squamous carcinoma who could benefit from second-line chemotherapy.
Oncology 2010;79(5-6):363-9.
2009: JAE SOOK SUNG; Young Mi Whang; Kyong Hwa Park; Jeong-Seon Ryu; Jong Gwon Choi; Jae Hong Seo; Sang Won Shin; Jun Suk Kim; Yeul Hong Kim
No association between promoter polymorphism of STK11 gene and lung cancer risk in the Korean population.
Cancer research and treatment : official journal of Korean Cancer Association 2009;41(4):211-7.
2009: Seung-Ho Baik; Bo Keun Jee; Jin-Soo Choi; Hyoung-Kyu Yoon; Kweon-Haeng Lee; Yeul Hong Kim; Young Lim
DNA profiling by array comparative genomic hybridization (CGH) of peripheral blood mononuclear cells (PBMC) and tumor tissue cell in non-small cell lung cancer (NSCLC).
Molecular biology reports 2009;36(7):1767-78.
2009: Jin Soo Choi; Woon Jeong Lee; Seung Ho Baik; Hyoung Kyu Yoon; Kweon-Haeng Lee; Yeul Hong Kim; Young Lim; Young-Pil Wang
Array CGH reveals genomic aberrations in human emphysema.
Lung 2009;187(3):165-72.
2009: Hyo Seon Choi; Youngin Lee; Kyong Hwa Park; JAE SOOK SUNG; Jong-Eun Lee; Eun-Soon Shin; Jeong-Seon Ryu; Yeul Hong Kim
Single-nucleotide polymorphisms in the promoter of the CDK5 gene and lung cancer risk in a Korean population.
Journal of human genetics 2009;54(5):298-303.
2009: Young Mi Whang; Kyong Hwa Park; Hae-Yun Jung; Uk Hyun Jo; Yeul Hong Kim
Microtubule-damaging agents enhance RASSF1A-induced cell death in lung cancer cell lines.
Cancer 2009;115(6):1253-66.
2009: Yeul Hong Kim; Hee Yun Seo; Yoon Tae Jeen; Hoon-Kyo Kim; Byoung Yong Shim; Jinmo Yang
Phase I dose escalation study of docetaxel with a fixed dose of S-1 in combination chemotherapy for advanced gastric cancer.
Cancer chemotherapy and pharmacology 2009;63(2):253-60.
2009: Jae Hong Seo; Yeul Hong Kim; Jun Suk Kim
Meta-analysis of pre-operative aromatase inhibitor versus tamoxifen in postmenopausal woman with hormone receptor-positive breast cancer.
Cancer chemotherapy and pharmacology 2009;63(2):261-6.
2008: Jung Eun Kim; Kyung Hee Koo; Yeul Hong Kim; Jeongwon Sohn; Yun Gyu Park
Identification of potential lung cancer biomarkers using an in vitro carcinogenesis model.
Experimental & molecular medicine 2008;40(6):709-20.
2008: DS Kim; JAE SOOK SUNG; Eun-Soon Shin; Jeong-Seon Ryu; In Keun Choi; Kyong Hwa Park; Yong Park; Eui Bae Kim; Seh Jong Park; Yeul Hong Kim
Association of single nucleotide polymorphisms in PIM-1 gene with the risk of Korean lung cancer.
Cancer research and treatment : official journal of Korean Cancer Association 2008;40(4):190-6.
2008: Eui Bae Kim; Yong Park; Seh Jong Park; DS Kim; Jee Won Kim; Hee Yun Seo; Hwa Jung Sung; In Keun Choi; Kyong Hwa Park; Sang Cheul Oh; Chul Won Choi; Byung Soo Kim; Yeul Hong Kim; Jun Suk Kim; Sang Won Shin; Chul Yong Kim; Kwang-Yoon Jung
Clinical factors related to suspected second primary lung cancer development in patients with head and neck cancer.
Cancer research and treatment : official journal of Korean Cancer Association 2008;40(4):178-83.
2008: Sle Gi Lo Han; Kyong Hwa Park; JAE SOOK SUNG; Young Mi Whang; Yeon Jung Kim; Eun-Soon Shin; Jae Won Lee; Hyo Jung Lee; Jeong-Seon Ryu; In Keun Choi; Jae Hong Seo; Yeul Hong Kim
Single nucleotide polymorphisms of IGFBP-3 gene and lung cancer risk in a Korean population.
Lung cancer (Amsterdam, Netherlands) 2008;62(2):152-61.
2008: Kyo-Cheol Mun; K T Lee; HJ Choi; K B Jin; Seung Yeup Han; Sung-Bae Park; Hyun-Chul Kim; E Y Ha; Yeul Hong Kim
Effects of cyclosporine on the production of the reactive oxygen species in the glial cells.
Transplantation proceedings 2008;40(8):2742-3.
2008: J H Jang; Koo Jeong Kang; Yeul Hong Kim; Yu Na Kang; In-Seon Lee
Reevaluation of experimental model of hepatic fibrosis induced by hepatotoxic drugs: an easy, applicable, and reproducible model.
Transplantation proceedings 2008;40(8):2700-3.
2008: K B Jin; HJ Choi; Haesook T Kim; Eun Ah Hwang; Seung Yeup Han; Sung-Bae Park; Hyun-Chul Kim; E Y Ha; Yeul Hong Kim; Seong-Il Suh; Kyo-Cheol Mun
Cytokine array after cyclosporine treatment in rats.
Transplantation proceedings 2008;40(8):2682-4.
2008: Hong Suk Song; Young Rok Do; Heung Moon Chang; Min Hee Ryu; Kyung Hee Lee; Yeul Hong Kim; Dae Sik Hong; Jae Yong Cho; Kyoung Eun Lee; Si Young Kim
A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer.
Cancer chemotherapy and pharmacology 2008;62(5):763-8.
2008: Yong Park; Jee Won Kim; DS Kim; Eui Bae Kim; Se Jong Park; JY Park; Woo Suk Choi; Jong Gyu Song; Hee Yun Seo; Sang Cheul Oh; Byung Soo Kim; Jong-Jae Park; Yeul Hong Kim; Jun Suk Kim
The Bone Morphogenesis Protein-2 (BMP-2) is associated with progression to metastatic disease in gastric cancer.
Cancer research and treatment : official journal of Korean Cancer Association 2008;40(3):127-32.
2008: JAE SOOK SUNG; Sle Gi Lo Han; Young Mi Whang; Eun-Soon Shin; Jae Won Lee; Hyo Jung Lee; Jeong-Seon Ryu; In Keun Choi; Kyong Hwa Park; Jun Suk Kim; Sang Won Shin; Elizabeth K Chu; Yeul Hong Kim
Putative association of the single nucleotide polymorphisms in RASSF1A promoter with Korean lung cancer.
Lung cancer (Amsterdam, Netherlands) 2008;61(3):301-8.
2008: Yeul Hong Kim; Hyun Cheol Chung; Won Ki Kang; Sook Ryun Park; Chul Soo Kim; Tae-Yue Kim; Sang Won Shin; Byung-Joo Park; Soo Jin Cha; Yung-Jue Bang
Pemetrexed and cisplatin in patients with advanced gastric cancer: a Korean cancer study group multicenter phase II study.
Cancer chemotherapy and pharmacology 2008;62(2):263-70.
2008: Jae Hong Seo; Hwa Jung Sung; Chul Won Choi; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Byoung-Hyun Min; Jun Suk Kim
Extrinsic nitric oxide donor partially reverses arginine deiminase induced cell growth inhibition through NFkappaB and Bcl-X L.
Investigational new drugs 2008;26(3):277-82.
2008: In Keun Choi; Yeul Hong Kim; Jun Suk Kim; Jae Hong Seo
PPAR-gamma ligand promotes the growth of APC-mutated HT-29 human colon cancer cells in vitro and in vivo.
Investigational new drugs 2008;26(3):283-8.
2008: Joong-Min Park; Yeul Hong Kim
Current approaches to gastric cancer in Korea.
Gastrointestinal cancer research : GCR 2008;2(3):137-44.
2008: Young A Yoo; Yeul Hong Kim; Jun Suk Kim; Jae Hong Seo
The functional implications of Akt activity and TGF-beta signaling in tamoxifen-resistant breast cancer.
Biochimica et biophysica acta 2008;1783(3):438-47.
2008: Uk Hyun Jo; Sle Gi Lo Han; Jae Hong Seo; Kyong Hwa Park; Jae Won Lee; Hyo Jung Lee; Jeong Seon Ryu; Yeul Hong Kim
The genetic polymorphisms of HER-2 and the risk of lung cancer in a Korean population.
BMC cancer 2008;8():359.
2008: Hae-Yun Jung; Young Mi Whang; JAE SOOK SUNG; Hyoung Doo Shin; Byung Lae Park; Jun Suk Kim; Sang Won Shin; Hee Yun Seo; Jae Hong Seo; Yeul Hong Kim
Association study of TP53 polymorphisms with lung cancer in a Korean population.
Journal of human genetics 2008;53(6):508-14.
2008: Jae Hong Seo; Yeul Hong Kim; Jun Suk Kim
Properties of the amniotic membrane may be applicable in cancer therapy.
Medical hypotheses 2008;70(4):812-4.
2007: Seok Jin Kim; Hye Jin Shin; Kwang-Yoon Jung; Seung-Kuk Baek; Bong Kyung Shin; Jungwoo Choi; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim; Egbert Oosterwijk
Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue.
Japanese journal of clinical oncology 2007;37(11):812-9.
2007: Yoon Seok Choi; Seok Jin Kim; DS Kim; Seh Jong Park; Yong Park; Hye Jin Shin; Kwang-Yoon Jung; Seung-Kuk Baek; Bong Kyung Shin; Jung Woo Choi; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
Glucose transporter-1 expression in squamous cell carcinoma of the tongue.
Cancer research and treatment : official journal of Korean Cancer Association 2007;39(3):109-15.
2007: Eun Jung Choi; Young Mi Whang; Seok Jin Kim; Hyun Jin Kim; Yeul Hong Kim
Combinational treatment with retinoic acid derivatives in non-small cell lung carcinoma in vitro.
Journal of Korean medical science 2007;22 Suppl():S52-60.
2007: Yeul Hong Kim; Kensei Yamaguchi; Yung-Jue Bang; Hiroya Takiuchi; Won Ki Kang; Atsushi Sato; Yoon-Koo Kang; Junichi Sakamoto; Chigusa Abe; Yuh Sakata
Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea Japan Collaborative Study Group Trial.
Japanese journal of clinical oncology 2007;37(7):501-8.
2007: Yuh Sakata; Jaffer A Ajani; Masashi Fujii; Ichinosuke Hyodo; Yeul Hong Kim
Global perspectives on chemotherapy for patients with gastric carcinoma: a roundtable discussion.
Gastrointestinal cancer research : GCR 2007;1(3):107-14.
2007: Jae Hong Seo; Sang Cheul Oh; Chul Won Choi; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim; Ae-Ree Kim; Jae-Bok Lee; Bum Hwan Koo
Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer.
Cancer chemotherapy and pharmacology 2007;59(2):269-74.
2007: Seh Jong Park; In Keun Choi; Hee Yun Seo; Hwa Jung Sung; Kyong Hwa Park; Seok Jin Kim; Sang Cheul Oh; Jae Hong Seo; Chul Won Choi; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
Reduced dose of imatinib for patients with chronic myeloid leukemia and low body surface area.
Acta haematologica 2007;118(4):219-21.
2007: In Keun Choi; Hee Yun Seo; Hwa Jung Sung; Kyong Hwa Park; Seok Jin Kim; Sang Cheul Oh; Jae Hong Seo; Chul Won Choi; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
Epirubicin, cisplatin, oral UFT, and leucovorin combination chemotherapy in advanced and metastatic esophageal cancer.
Medical oncology (Northwood, London, England) 2007;24(1):33-7.
2007: Hae-Yun Jung; JAE SOOK SUNG; Young Mi Whang; Hyoung Doo Shin; Byung Lae Park; Jun Suk Kim; Sang Won Shin; Hee Yun Seo; Hwa Jung Sung; In Keun Choi; Sang Cheul Oh; Jae Hong Seo; Yeul Hong Kim
Lack of association of fragile histidine triad (FHIT) polymorphisms with lung cancer in the Korean population.
Journal of human genetics 2007;52(8):668-74.
2007: Soo-Young Yoon; Hwa Jung Sung; Kyong Hwa Park; In Keun Choi; Seok Jin Kim; Sang Cheul Oh; Jae Hong Seo; Chul Won Choi; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
Telomere length shortening of peripheral blood mononuclear cells in solid-cancer patients undergoing standard-dose chemotherapy might be correlated with good treatment response and neutropenia severity.
Acta haematologica 2007;118(1):30-7.
2007: Yong-Woo Choi; Jin Soo Choi; Long Tai Zheng; Yun Jeong Lim; Hyoung Kyu Yoon; Yeul Hong Kim; Young-Pil Wang; Young Lim
Comparative genomic hybridization array analysis and real time PCR reveals genomic alterations in squamous cell carcinomas of the lung.
Lung cancer (Amsterdam, Netherlands) 2007;55(1):43-51.
2006: Jin Soo Choi; Long Tai Zheng; Eunyoung Ha; Yun Jeong Lim; Yeul Hong Kim; Young-Pil Wang; Young Lim
Comparative genomic hybridization array analysis and real-time PCR reveals genomic copy number alteration for lung adenocarcinomas.
Lung 2006;184(6):355-62.
2006: Kyong Hwa Park; Sle Gi Lo Han; Young Mi Whang; Hyo Jung Lee; Young Do Yoo; Jae Won Lee; Sang Won Shin; Yeul Hong Kim
Single nucleotide polymorphisms of the TGFB1 gene and lung cancer risk in a Korean population.
Cancer genetics and cytogenetics 2006;169(1):39-44.
2006: Hwa Jung Sung; Seok Jin Kim; Hee Yun Seo; Hye Ryoung Sul; Jong Gwon Choi; In Keun Choi; Kyong Hwa Park; Sang Cheul Oh; Jae Hong Seo; Chul Won Choi; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
Prospective analysis of treatment outcome and prognostic factors in patients with T-cell lymphomas treated by CEOP-B: single institutional study.
British journal of haematology 2006;134(1):45-53.
2006: Jee Hyun Kim; Si Young Kim; Kyung Hae Jung; Keunchil Park; Cheol Won Suh; Ho Young Lim; Yeul Hong Kim; Baek-Yeol Ryoo; Eun Kyung Cho; Byung Joo Park; Dae Seog Heo
Randomized phase II study of gemcitabine plus cisplatin versus etoposide plus cisplatin for the treatment of locally advanced or metastatic non-small cell lung cancer: Korean Cancer Study Group experience.
Lung cancer (Amsterdam, Netherlands) 2006;52(1):75-81.
2006: Seok Jin Kim; Hee Yun Seo; Jong Gwon Choi; Hye Ryoung Sul; Hwa Jung Sung; Kyong Hwa Park; In Keun Choi; Sang Cheul Oh; Soo-Young Yoon; Jae Hong Seo; Chul Won Choi; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
Phase II study with a combination of epirubicin, cisplatin, UFT, and leucovorin in advanced hepatocellular carcinoma.
Cancer chemotherapy and pharmacology 2006;57(4):436-42.
2006: Kyong Hwa Park; Young-Hee Rho; Seong-Jae Choi; Suk-Joo Hong; Ju-Han Lee; In Keun Choi; Seok-Jin Kim; Jae Hong Seo; Chul Won Choi; Byung-Soo Kim; Sang Won Shin; Yeul Hong Kim; Gwan Gyu Song; Jun Suk Kim
Acute arthritis of carpal bones secondary to metastatic gastric cancer.
Clinical rheumatology 2006;25(2):258-61.
2006: Ukhyun Jo; Young Mi Whang; Han Kyeom Kim; Yeul Hong Kim
AKAP12alpha is associated with promoter methylation in lung cancer.
Cancer research and treatment : official journal of Korean Cancer Association 2006;38(3):144-51.
2006: Soo-Young Yoon; Yoo Jung Lee; Jae Hong Seo; Hwa Jung Sung; Kyong Hwa Park; In Keun Choi; Seok Jin Kim; Sang Cheul Oh; Chul Won Choi; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
uPAR expression under hypoxic conditions depends on iNOS modulated ERK phosphorylation in the MDA-MB-231 breast carcinoma cell line.
Cell research 2006;16(1):75-81.
2006: Kyoung-Soo Choi; Soo-Yeon Park; Sun-Hee Baek; Rama Dey-Rao; Young-Mee Park; Haitao Zhang; Clement Ip; Eun-Mi Park; Yeul Hong Kim; Jong Hoon Park
Analysis of protein redox modification by hypoxia.
Preparative biochemistry & biotechnology 2006;36(1):65-79.
2006: Jong-Sik Lee; Yong-Beom Ma; Kyoung-Soo Choi; Soo-Yeon Park; Sun-Hee Baek; Young-Mee Park; Ke Zu; Haitao Zhang; Clement Ip; Yeul Hong Kim; Eun-Mi Park
Neural network-based analysis of thiol proteomics data in identifying potential selenium targets.
Preparative biochemistry & biotechnology 2006;36(1):37-64.
2005: Chul Won Choi; Juneyoung Lee; Kyong Hwa Park; In Keun Choi; Seok Jin Kim; Jae Hong Seo; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
Incidence of anemia in older Koreans: community-based cohort study.
Archives of gerontology and geriatrics 2005;41(3):303-9.
2005: Young Mi Whang; Eun Jung Choi; Jae Hong Seo; Jun Suk Kim; Young Do Yoo; Yeul Hong Kim
Hyperacetylation enhances the growth-inhibitory effect of all-trans retinoic acid by the restoration of retinoic acid receptor beta expression in head and neck squamous carcinoma (HNSCC) cells.
Cancer chemotherapy and pharmacology 2005;56(5):543-55.
2005: Seok Jin Kim; Byung Soo Kim; Suck Won Ryu; Ji Hyun Yoo; Jee Hyun Oh; Chang Hee Song; Sun Haeng Kim; Dong Seop Choi; Jae Hong Seo; Chul Won Choi; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
Hematopoietic differentiation of embryoid bodies derived from the human embryonic stem cell line SNUhES3 in co-culture with human bone marrow stromal cells.
Yonsei medical journal 2005;46(5):693-9.
2005: Kyong Hwa Park; In Keun Choi; Seok-Jin Kim; Sang Cheul Oh; Jae Hong Seo; Chul Won Choi; Byung-Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
The efficacy of epirubicin, cisplatin, uracil/tegafur, and leucovorin in patients with advanced biliary tract carcinoma.
Cancer 2005;103(11):2338-43.
2005: Chul Won Choi; Woo Ri Cho; Kyong Hwa Park; In Keun Choi; Jae Hong Seo; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim; Juneyoung Lee
The cutoff value of serum ferritin for the diagnosis of iron deficiency in community-residing older persons.
Annals of hematology 2005;84(6):358-61.
2005: Young Mi Whang; Yeul Hong Kim; Jun Suk Kim; Young Do Yoo
RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression.
Cancer research 2005;65(9):3682-90.
2005: Yeul Hong Kim
Chemotherapy for advanced gastric cancer: slow but further progress.
Cancer research and treatment : official journal of Korean Cancer Association 2005;37(2):79-86.
2005: Hae-Yun Jung; Sun-Hee Park; Young Do Yoo; Jun Suk Kim; Yeul Hong Kim
CDK2/4 regulate retinoic acid-induced G1 arrest in hepatocellular carcinoma cells.
Hepatology research : the official journal of the Japan Society of Hepatology 2005;31(3):143-52.
2005: Jae Hong Seo; Chul Won Choi; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim; Sang Woo Lee; Jae Hyun Choi; Yung Tae Park; Young-Jae Mok; Chong Suk Kim; Jun Suk Kim
Follow-up study of peripheral blood carcinoembryonic antigen mRNA using reverse transcription-polymerase chain reaction as an early marker of clinical recurrence in patients with curatively resected gastric cancer.
American journal of clinical oncology 2005;28(1):24-9.
2005: Chul Won Choi; Kyong Hwa Park; In Keun Choi; Seok Jin Kim; Jae Hong Seo; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
Prevalence of iron deficiency anemia in community-dwelling older persons as measured by the transferrin receptor-ferritin index.
Acta haematologica 2005;114(3):180-2.
2005: Seok Jin Kim; Jae Hong Seo; Yoo Jung Lee; Ji Hye Yoon; Chul Won Choi; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
Autocrine vascular endothelial growth factor/vascular endothelial growth factor receptor-2 growth pathway represents a cyclooxygenase-2-independent target for the cyclooxygenase-2 inhibitor NS-398 in colon cancer cells.
Oncology 2005;68(2-3):204-11.
2004: In Keun Choi; Byung-Soo Kim; Kyung-A Lee; Sookwon Ryu; Hee Yun Seo; Hye Ryoung Sul; Jong Gwon Choi; Hwa Jung Sung; Kyong Hwa Park; Soo-Young Yoon; Sang Cheul Oh; Jae Hong Seo; Chul Won Choi; Sang Won Shin; Soo-Young Yoon; Yunjung Cho; Young-Kee Kim; Yeul Hong Kim; Jun Suk Kim
Efficacy of imatinib mesylate (STI571) in chronic neutrophilic leukemia with t(15;19): case report.
American journal of hematology 2004;77(4):366-9.
2004: Jae Hong Seo; Dae-Yeon Cho; Se-Hyun Ahn; Kyung-Sik Yoon; Chang-Soo Kang; Hyun Mi Cho; Hyeon Sook Lee; Jae Jin Choe; Chul Won Choi; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim; Gil-Soo Son; Jae-Bok Lee; Bum Hwan Koo
BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.
Human mutation 2004;24(4):350.
2004: Chul Won Choi; Juneyoung Lee; Kyong Hwa Park; Soo-Young Yoon; In Keun Choi; Sang Cheul Oh; Jae Hong Seo; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
Prevalence and characteristics of anemia in the elderly: cross-sectional study of three urban Korean population samples.
American journal of hematology 2004;77(1):26-30.
2004: Sang Cheul Oh; Chul Won Choi; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jin Soo Lee; Min Ja Kim; Woon Yong Jung; Han Kyeom Kim; Bum-Woo Yeom; In-Sun Kim; Jun Suk Kim
NK/T-cell lymphoma associated with Epstein-Barr virus in a patient infected with human immunodeficiency virus: an autopsy case.
International journal of hematology 2004;79(5):480-3.
2004: Seok Jin Kim; In Keun Choi; Kyong Hwa Park; Soo-Young Yoon; Sang Cheul Oh; Jae Hong Seo; Chul Won Choi; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
Serum vascular endothelial growth factor per platelet count in hepatocellular carcinoma: correlations with clinical parameters and survival.
Japanese journal of clinical oncology 2004;34(4):184-90.
2003: Chul Won Choi; Hwa Jung Sung; Kyong Hwa Park; Soo-Young Yoon; Seok Jin Kim; Sang Cheul Oh; Jae Hong Seo; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia.
American journal of hematology 2003;73(4):263-6.
2003: Young Ho Yun; Dae Seog Heo; In Goo Lee; Hyun Sik Jeong; Hyo Jin Kim; Si-Young Kim; Yeul Hong Kim; You-Ja Ro; Sung Soo Yoon; Ki Hyeong Lee; Bong Yul Huh
Multicenter study of pain and its management in patients with advanced cancer in Korea.
Journal of pain and symptom management 2003;25(5):430-7.
2002: Jong Kuk Park; Young Min Chung; Seongman Kang; Jae-Uk Kim; Yun-Taik Kim; Hyung Jung Kim; Yeul Hong Kim; Jun Suk Kim; Young Do Yoo
c-Myc exerts a protective function through ornithine decarboxylase against cellular insults.
Molecular pharmacology 2002;62(6):1400-8.
2002: Chul Won Choi; Chang Won Paek; Jae Hong Seo; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
ESHAP salvage therapy for relapsed or refractory non-Hodgkin's lymphoma.
Journal of Korean medical science 2002;17(5):621-4.
2001: Chul Won Choi; Byung-Soo Kim; Jae Hong Seo; Sang Won Shin; Yeul Hong Kim; J S Kim; S K Sohn; Jun Suk Kim; D G Shin; H M Ryoo; K H Lee; J J Lee; Ik-Joo Chung; Hyeoung-Joon Kim; J Y Kwak; C Y Yim; J S Ahn; J A Lee; Y S Park
Response to high-dose intravenous immune globulin as a valuable factor predicting the effect of splenectomy in chronic idiopathic thrombocytopenic purpura patients.
American journal of hematology 2001;66(3):197-202.
2001: Chul Won Choi; Byung Soo Kim; J H Seo; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
Long-term engraftment stability of peripheral blood stem cells cryopreserved using the dump-freezing method in a -80 degrees C mechanical freezer with 10% dimethyl sulfoxide.
International journal of hematology 2001;73(2):245-50.
2000: N H Kim; Jee Hyun Oh; K M Choi; Yeul Hong Kim; S H Baik; Dong Seop Choi; Seok Jin Kim
Serum ferritin in healthy subjects and type 2 diabetic patients.
Yonsei medical journal 2000;41(3):387-92.